BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IBSAL - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IBSAL
X-ORIGINAL-URL:https://ibsal.es
X-WR-CALDESC:Eventos para IBSAL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260101
DTEND;VALUE=DATE:20280102
DTSTAMP:20260429T215246
CREATED:20251126T071112Z
LAST-MODIFIED:20251126T074629Z
UID:17563-1767225600-1830383999@ibsal.es
SUMMARY:PARTENARIADO European Partnership for Personalised Medicine EP PerMed
DESCRIPTION:Características\nSe ha publicado convocatoria transnacional conjunta del partenariado European Partnership for Personalised Medicine (EP PerMed)\, Joint Transnational Call (JTC) 2026 Personalised Medicine for CARdiovascular\, MEtabolic\, and kidNey diseases (CARMEN2026) \nEn esta convocatoria se financiarán proyectos de investigación en salud humana sobre estrategias innovadoras de medicina personalizada para pacientes con enfermedades cardiovasculares\, metabólicas o renales. Los proyectos de investigación podrán centrarse en una única enfermedad o abordar estas condiciones de manera combinada. \nSe valorarán positivamente los proyectos de investigación que combinen un enfoque de medicina personalizada con care strategies dirigidas a vías biológicas compartidas o a mecanismos subyacentes comunes de las enfermedades cardiovasculares\, metabólicas y renales. \nLa convocatoria está cofinanciada por la Unión Europea y cuenta con la participación de 39 organizaciones financiadoras de 27 países\, con un presupuesto total estimado superior a 38 millones de euros. \nAsimismo\, en esta convocatoria participa como organismo financiador nacional\, el Instituto de Salud Carlos III (ISCIII). \nRequisitos\nProposals should address one or more of the following aspects: \n\nDevelopment and validation of innovative personalised therapeutic approaches for cardiovascular\, metabolic or kidney diseases through testing in relevant pre-clinical models (e.g.\, human cell cultures\, organoids\, organs-on-chips\, disease-specific animal models\, or in silico models).\nIdentification and validation of molecular markers/signatures or cutting-edge technologies (see also point 2 below) to monitor treatment response in patients with cardiovascular\, metabolic or kidney diseases in order to tailor treatment pathways. This may include the analysis of the treatment effectiveness or treatment-related (including multi-medication) adverse effects as well as dose optimisation.\nIdentification and validation of stratifying molecular markers/signatures or stratifying diagnostic technologies for early disease risk prediction and prevention of disease worsening or comorbidities in patients with cardiovascular\, metabolic or kidney diseases\, thereby delaying the progression to cardiovascular-kidney-metabolic syndrome.\n\n  \nResearch projects that combine a personalised medicine approach with care strategies targeting shared biological pathways or common underlying mechanisms of cardiovascular\, metabolic and kidney diseases are welcome. \nProjects funded under this call are furthermore required to include a dedicated work package focussing on the question of the translation or implementation of the research outcomes into clinical practice with a focus on e.g. patient outcome\, patient preferences\, costs\, reimbursement\, education (to healthcare providers\, patients and citizens)\, ELSA (ethical\, legal and societal aspect) or accessibility at the point of care. \nPlazo de presentación.\nEn la siguiente table se detallan las diferentes fechas: \n\n\n\nPhase\nDate\n\n\n\n\nCall opens\nNovember 25\, 2025\n\n\nDeadline pre-proposals\nFebruary 10\, 2026\, (14:00 CET)\n\n\nNotification of the results of the pre-proposal\nMay 5\, 2026\n\n\nDeadline fullproposals\nJune 9\, 2026\, (14:00 CET)\n\n\nRebuttal stage\nMid/end of August\, 2026\n\n\nCommunication of the funding decisions\nOctober 2026\n\n\n\n  \n 
URL:https://ibsal.es/evento/partenariado-european-partnership-for-personalised-medicine-ep-permed/
CATEGORIES:Convocatorias para la investigación
END:VEVENT
END:VCALENDAR